Targeting uPA-uPAR interaction to improve intestinal epithelial barrier integrity in inflammatory bowel disease - eBioMedicine

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation

Full article: Recent progress in plant-derived polysaccharides with prebiotic potential for intestinal health by targeting gut microbiota: a review

Pathologically catalyzed physical coating restores the intestinal barrier for inflammatory bowel disease therapy, Journal of Nanobiotechnology

Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics

Nutrients, Free Full-Text

TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity. - Abstract - Europe PMC

Gastrointestinal Disorders, Free Full-Text

Lancet子刊丨IBD治疗新方向？uPA-uPAR有效调控肠黏膜屏障功能，提供抗炎新策略- 知乎

Frontiers Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer

TRIM40 is a pathogenic driver of inflammatory bowel disease subverting intestinal barrier integrity. - Abstract - Europe PMC

uPAR Antibody AF807 from R&D Systems, a Bio-Techne Brand